DNA Methylation: Roles in Rheumatoid Arthritis

Cell Biochemistry and Biophysics

Volumn 70, Issue 1, 2014, Pages 77-82

  Yuan, Feng Lai ^a   Li, Xia ^a   Xu, Rui Sheng ^a   Jiang, Dong Lin ^a   Zhou, Xiao Gang ^b  

^a NANTONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

DNA hypomethylation; Fibroblast like synoviocytes; Rheumatoid arthritis

Indexed keywords

ARTHRITIS, RHEUMATOID; DNA METHYLATION; DRUG EFFECTS; GENETICS; HUMAN; MOLECULARLY TARGETED THERAPY;

ARTHRITIS, RHEUMATOID; DNA METHYLATION; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 84906254700     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-9913-8     Document Type: Review

References (56)

1. Li, X., Yuan, F. L., Lu, W. G., Zhao, Y. Q., Li, C. W., Li, J. P., et al. (2010). The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochemical and Biophysical Research Communications, 397, 131-135.
2. Yuan, F. L., Li, X., Lu, W. G., Li, C. W., Xu, R. S., & Dong, J. (2011). IL-33: A promising therapeutic target for rheumatoid arthritis? Expert Opinion on Therapeutic Targets, 15, 529-534.
3. Klein, K., Ospelt, C., & Gay, S. (2012). Epigenetic contributions in the development of rheumatoid arthritis. Arthritis Research and Therapy, 14, 227.
4. Bartok, B., & Firestein, G. S. (2010). Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunological Reviews, 233, 233-255.
5. Peck, A., & Mellins, E. D. (2009). Breaking old paradigms: Th17 cells in autoimmune arthritis. Clinical Immunology, 132, 295-304.
6. Davignon, J. L., Hayder, M., Baron, M., Boyer, J. F., Constantin, A., Apparailly, F., et al. (2013). Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. Rheumatology (Oxford), 52, 590-598.
7. Maruotti, N., Crivellato, E., Cantatore, F. P., Vacca, A., & Ribatti, D. (2007). Mast cells in rheumatoid arthritis. Clinical Rheumatology, 26, 1-4.
8. Zhao, Y., Zhang, A., Du, H., Guo, S., Ning, B., & Yang, S. (2012). Tolerogenic dendritic cells and rheumatoid arthritis: Current status and perspectives. Rheumatology International, 32, 837-844.
9. Noss, E. H., & Brenner, M. B. (2008). The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunological Reviews, 223, 252-270.
10. Firestein, G. S. (2003). Evolving concepts of rheumatoid arthritis. Nature, 423, 356-361.
11. Miao, C. G., Yang, Y. Y., He, X., Li, X. F., Huang, C., Huang, Y., et al. (2013). Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cellular Signalling, 25(10), 2069-2078.
12. Bottini, N., & Firestein, G. S. (2013). Duality of fibroblast-like synoviocytes in RA: Passive responders and imprinted aggressors. Nature Reviews Rheumatology, 9, 24-33.
13. Zhang, Y., Dong, J., He, P., Li, W., Zhang, Q., Li, N., et al. (2012). Genistein inhibit cytokines or growth factor-induced proliferation and transformation phenotype in fibroblast-like synoviocytes of rheumatoid arthritis. Inflammation, 35, 377-387.
14. Karouzakis, E., Gay, R. E., Michel, B. A., Gay, S., & Neidhart, M. (2009). DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 60, 3613-3622.
15. Neidhart, M., Rethage, J., Kuchen, S., Kunzler, P., Crowl, R. M., Billingham, M. E., et al. (2000). Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis and Rheumatism, 43, 2634-2647.
16. Karouzakis, E., Gay, R. E., Gay, S., & Neidhart, M. (2012). Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 64, 1809-1817.
17. Fu, L. H., Ma, C. L., Cong, B., Li, S. J., Chen, H. Y., & Zhang, J. G. (2011). Hypomethylation of proximal CpG motif of interleukin-10 promoter regulates its expression in human rheumatoid arthritis. Acta Pharmacologica Sinica, 32, 1373-1380.
18. Nile, C. J., Read, R. C., Akil, M., Duff, G. W., & Wilson, A. G. (2008). Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis and Rheumatism, 58, 2686-2693.
19. Ishida, K., Kobayashi, T., Ito, S., Komatsu, Y., Yokoyama, T., Okada, M., et al. (2012). Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. Journal of Periodontology, 83, 917-925.
20. Lin, S. Y., Hsieh, S. C., Lin, Y. C., Lee, C. N., Tsai, M. H., Lai, L. C., et al. (2012). A whole genome methylation analysis of systemic lupus erythematosus: Hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity. Genes and Immunity, 13, 214-220.
21. Liu, C. C., Fang, T. J., Ou, T. T., Wu, C. C., Li, R. N., Lin, Y. C., et al. (2011). Global DNA methylation, DNMT1, and MBD2 in patients with rheumatoid arthritis. Immunology Letters, 135, 96-99.
22. Nakano, K., Boyle, D. L., & Firestein, G. S. (2013). Regulation of DNA methylation in rheumatoid arthritis synoviocytes. Journal of Immunology, 190, 1297-1303.
23. Delcuve, G. P., Rastegar, M., & Davie, J. R. (2009). Epigenetic control. Journal of Cellular Physiology, 219, 243-250.
24. Li, E. (2002). Chromatin modification and epigenetic reprogramming in mammalian development. Nature Reviews Genetics, 3, 662-673.
25. Turek-Plewa, J., & Jagodzinski, P. P. (2005). The role of mammalian DNA methyltransferases in the regulation of gene expression. Cellular and Molecular Biology Letters, 10, 631-647.
26. Weber, M., & Schubeler, D. (2007). Genomic patterns of DNA methylation: Targets and function of an epigenetic mark. Current Opinion in Cell Biology, 19, 273-280.
27. Malygin, E. G., & Hattman, S. (2012). DNA methyltransferases: Mechanistic models derived from kinetic analysis. Critical Reviews in Biochemistry and Molecular Biology, 47, 97-193.
28. Zhou, Y., & Lu, Q. (2008). DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients. Autoimmunity Reviews, 7, 376-383.
29. Pradhan, S., & Esteve, P. O. (2003). Mammalian DNA (cytosine-5) methyltransferases and their expression. Clinical Immunology, 109, 6-16.
30. Hendrich, B., & Tweedie, S. (2003). The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends in Genetics, 19, 269-277.
31. Baranzini, S. E., Mudge, J., van Velkinburgh, J. C., Khankhanian, P., Khrebtukova, I., Miller, N. A., et al. (2010). Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature, 464, 1351-1356.
32. Boyd-Kirkup, J. D., Green, C. D., Wu, G., Wang, D., & Han, J. D. (2013). Epigenomics and the regulation of aging. Epigenomics, 5, 205-227.
33. Gros, C., Fahy, J., Halby, L., Dufau, I., Erdmann, A., Gregoire, J. M., et al. (2012). DNA methylation inhibitors in cancer: recent and future approaches. Biochimie, 94, 2280-2296.
34. Kulis, M., & Esteller, M. (2010). DNA methylation and cancer. Advances in Genetics, 70, 27-56.
35. Viatte, S., Plant, D., & Raychaudhuri, S. (2013). Genetics and epigenetics of rheumatoid arthritis. Nature Reviews Rheumatology, 9, 141-153.
36. Watt, F., & Molloy, P. L. (1988). Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes and Development, 2, 1136-1143.
37. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., et al. (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
38. Majumdar, S., Buckles, E., Estrada, J., & Koochekpour, S. (2011). Aberrant DNA methylation and prostate cancer. Current Genomics, 12, 486-505.
39. Backdahl, L., Bushell, A., & Beck, S. (2009). Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. International Journal of Biochemistry and Cell Biology, 41, 176-184.
40. Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., & Johnson, M. (1990). Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis and Rheumatism, 33, 1665-1673.
41. Corvetta, A., Della Bitta, R., Luchetti, M. M., & Pomponio, G. (1991). 5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases. The Journal of Chromatography, 566, 481-491.
42. Nakano, K., Whitaker, J. W., Boyle, D. L., Wang, W., & Firestein, G. S. (2013). DNA methylome signature in rheumatoid arthritis. Annals of the Rheumatic Diseases, 72, 110-117.
43. Park, S. H., Kim, S. K., Choe, J. Y., Moon, Y., An, S., Park, M. J., et al. (2013). Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis. Molecules and Cells, 35, 298-304.
44. Bian, E. B., Huang, C., Wang, H., Wu, B. M., Zhang, L., Lv, X. W., et al. (2013). DNA methylation: New therapeutic implications for hepatic fibrosis. Cellular Signalling, 25, 355-358.
45. Karouzakis, E., Rengel, Y., Jungel, A., Kolling, C., Gay, R. E., Michel, B. A., et al. (2011). DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes and Immunity, 12, 643-652.
46. Takami, N., Osawa, K., Miura, Y., Komai, K., Taniguchi, M., Shiraishi, M., et al. (2006). Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis and Rheumatism, 54, 779-787.
47. Chabchoub, G., Uz, E., Maalej, A., Mustafa, C. A., Rebai, A., Mnif, M., et al. (2009). Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases. Arthritis Research and Therapy, 11, R106.
48. Liao, J., Liang, G., Xie, S., Zhao, H., Zuo, X., Li, F., et al. (2012). CD40L demethylation in CD4(+) T cells from women with rheumatoid arthritis. The Journal of Clinical Immunology, 145, 13-18.
49. Whitaker, J. W., Shoemaker, R., Boyle, D. L., Hillman, J., Anderson, D., Wang, W., et al. (2013). An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype. Genome Medicine, 5, 40.
50. Stanczyk, J., Ospelt, C., Karouzakis, E., Filer, A., Raza, K., Kolling, C., et al. (2011). Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis and Rheumatism, 63, 373-381.
51. Niederer, F., Trenkmann, M., Ospelt, C., Karouzakis, E., Neidhart, M., Stanczyk, J., et al. (2012). Down-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis and Rheumatism, 64, 1771-1779.
52. de la Rica, L., Urquiza, J. M., Gomez-Cabrero, D., Islam, A. B., Lopez-Bigas, N., Tegner, J., et al. (2013). Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression. Journal of Autoimmunity, 41, 6-16.
53. Miao, C. G., Yang, Y. Y., He, X., Xu, T., Huang, C., Huang, Y., et al. (2013). New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery. Cellular Signalling, 25, 1118-1125.
54. Miao, C. G., Yang, Y. Y., He, X., & Li, J. (2013). New advances of DNA methylation and histone modifications in rheumatoid arthritis, with special emphasis on MeCP2. Cellular Signalling, 25, 875-882.
55. Catalano, M. G., Fortunati, N., & Boccuzzi, G. (2012). Epigenetics modifications and therapeutic prospects in human thyroid cancer. Frontiers in Endocrinology (Lausanne), 3, 40.
56. Miao, C. G., Huang, C., Huang, Y., Yang, Y. Y., He, X., Zhang, L., et al. (2013). MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats. Cellular Signalling, 25, 598-608.